The EBV-dUTPase localized in infiltrating plasma-cell aggregates near glomeruli where neighboring cells expressing increased toll-like receptor 2 (TLR2) and IL-17 protein levels were observed, which suggests that EBV-dUTPase may exacerbate the immunopathologies in some LN patients [42]. Here, TLR2 is linked to lobular neoplasia.